NDC 73239-1902 Numbing Cream

Lidocaine

NDC Product Code 73239-1902

NDC CODE: 73239-1902

Proprietary Name: Numbing Cream What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.

Non-Proprietary Name: Lidocaine What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

Drug Use Information

Drug Use Information
The drug use information is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate. This information is not individual medical advice and does not substitute for the advice of a health care professional. Always ask a health care professional for complete information about this product and your specific health needs.

  • This medication is used to relieve nerve pain after shingles (infection with the herpes zoster virus). This type of pain is called post-herpetic neuralgia. Lidocaine helps to reduce sharp/burning/aching pain as well as discomfort caused by skin areas that are overly sensitive to touch. Lidocaine belongs to a class of drugs known as local anesthetics. It works by causing a temporary loss of feeling in the area where you apply the patch.

NDC Code Structure

  • 73239 - Kanamed Inc.

NDC 73239-1902-1

Package Description: 100 mL in 1 TUBE

NDC Product Information

Numbing Cream with NDC 73239-1902 is a a human over the counter drug product labeled by Kanamed Inc.. The generic name of Numbing Cream is lidocaine. The product's dosage form is cream and is administered via topical form.

Labeler Name: Kanamed Inc.

Dosage Form: Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Numbing Cream Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

  • LIDOCAINE 5 mg/100mL

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • ALOE VERA WHOLE (UNII: KIZ4X2EHYX)
  • HEMP (UNII: TD1MUT01Q7)
  • WATER (UNII: 059QF0KO0R)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Kanamed Inc.
Labeler Code: 73239
FDA Application Number: part348 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 10-16-2019 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2020 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

* Please review the disclaimer below.

Numbing Cream Product Label Images

Numbing Cream Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Otc - Active Ingredient

Lidocaine 5%

Indications & Usage

Temporarily relieves minor pain

Inactive Ingredient

  • Hemp seed oilClove OilTea Tree OilGlycerineStearic AcidEDTAArcel 165Carbopol U-10,Cetyl AlcoholBHTCetearyl AlcoholCetearyl GlucosidePhenoxyethanolEthylhexlglycerinDM WaterCyclopentasiloxanePhenyl TrimethiconeDimethiconolC12-15 Alkyl BenzoateDimethicone CrosspolymerCaustic Soda/Sodium HydroxideCapric Caprylic Triglyceride

Dosage & Administration

Adults and children over 12 years of age: Apply a thin layer to affected area every 6 to 8 hours, not to exceed 3 applications in a 24 hour period.Children 12 years or younger: consult a doctor.

Warnings

  • For external use onlyOnly use as directedDo not allow contact with eyesDo not bandage or apply local heat such as heating pads to the area of useSTOP use and ask a doctor if:symptoms last more than 7 days or clear up and occur again within a few dayscondition worsens

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.

Otc - Purpose

Temporarily relieves minor pain​

Other Safety Information

Store at room temperature

* Please review the disclaimer below.